Three-dimensional laparoscopy vs 2-dimensional laparoscopy with high-definition technology for abdominal surgery: a systematic review - 18/04/17
, Jakob Burcharth, M.D., Ph.D. b, Hans-Christian Pommergaard, M.D., Ph.D. c, Niels Kildebro, M.D. a, Jacob Rosenberg, M.D. aAbstract |
Background |
This systematic review investigates newer generation 3-dimensional (3D) laparoscopy vs 2-dimensional (2D) laparoscopy in terms of error rating, performance time, and subjective assessment as early comparisons have shown contradictory results due to technological shortcomings.
Data sources |
This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Randomized controlled trials (RCTs) comparing newer generation 3D-laparoscopy with 2D-laparoscopy were included through searches in Pubmed, EMBASE, and Cochrane Central Register of Controlled Trials database.
Conclusions |
Of 643 articles, 13 RCTs were included, of which 2 were clinical trials. Nine of 13 trials (69%) and 10 of 13 trials (77%) found a significant reduction in performance time and error, respectively, with the use of 3D-laparoscopy. Overall, 3D-laparoscopy was found to be superior or equal to 2D-laparoscopy. All trials featuring subjective evaluation found a superiority of 3D-laparoscopy. More clinical RCTs are still awaited for the convincing results to be reproduced.
Le texte complet de cet article est disponible en PDF.Highlights |
• | A majority of RCTs found reduced performance time and error with 3D-laparoscopy. |
• | Subjective evaluation was superior for 3D-laparoscopy. |
• | All experimental trials showed an advantage for 3D-laparoscopy. |
• | The clinical trials showed mixed results between 3D- or 2D-laparoscopy. |
• | Newer generation 3D-laparoscopy is superior to or equal to 2D-laparoscopy. |
Keywords : Three-dimensional laparoscopy, Imaging, Minimally invasive surgery
Plan
| There were no relevant financial relationships or any sources of support in the form of grants, equipment, or drugs. |
|
| The authors declare no conflicts of interest. |
Vol 213 - N° 1
P. 159-170 - janvier 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
